<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

NuFund Venture Group Highlights Eyegenex’s Innovative Breakthroughs in Ophthalmic Care

Default sub title

minute read

by CityBiz | July 16, 2024
placeholder

Ram Nagaraj, PhD, professor of ophthalmology at the University of Colorado School of Medicine and chief scientific advisor for EyeGenex, has obtained new patents in the pursuit of pioneering drugs for glaucoma and diabetic retinopathy to prevent blindness. 

 

 

Topics: Press Coverage